Nu Skin (NUS) Q3 2026 Earnings Call Transcript

Nu Skin reported Q3 revenue of $311 million and adjusted EPS of $0.10, both within management’s guidance, but total customers fell 18% year over year to 609,469 and adjusted operating margin declined to 3.7% from 5.9%. Rhyz manufacturing revenue grew 19.3% to $56.8 million, while management forecast full-year revenue of $1.26 billion-$1.29 billion, a 13%-15% annual decline. Prysm iO scan-to-purchase conversion doubled to 10% after the app’s version 2.0 rollout, which includes an AI integration; management said the East-West operating model is intended to improve efficiency and profitability over time.

Analysis

The central risk is not this quarter’s execution but whether cost actions can outrun a shrinking sales network. Lower selling and G&A costs can protect near-term cash earnings, yet persistent customer and leader attrition would leave less scale to absorb fixed costs and could make further cuts self-reinforcing: weaker support and incentives may accelerate channel losses. Rhyz growth is not yet a clean offset; management attributes lower consolidated gross margin partly to business mix, so growth there should not be valued as a margin-positive replacement without segment profitability and cash-conversion disclosure.

Prysm is a plausible engagement lever, but the 10% scan-to-purchase figure is an early company-reported metric, not evidence of incremental customer acquisition or durable repeat purchasing. Scans include existing subscribers and repeat scans, making the denominator and cohort economics important. Verify conversion by new versus existing customer, repeat rate, device economics, and attributable revenue before underwriting a platform multiple.

Near term, guidance and adjusted EPS in line with expectations may limit an earnings-driven catalyst; the more important 1–3 month test is Q4 customer/channel stabilization and delivery against EPS guidance after transition costs. India and the mid-2027 product pipeline are 6–18 month options, not current offsets to channel contraction. The contrarian upside case is that organizational simplification and social-commerce training stabilize productivity before headline customer counts recover. Falsification of the bearish thesis would be sequential improvement in customers and paid affiliates alongside stable core gross margin and better operating margin—not device engagement alone.

Key Decisions for Investors

• Keep NUS underweight versus a diversified consumer-staples exposure; do not add on Prysm engagement claims alone. Reassess if customer and paid-affiliate declines materially moderate over the next two reported quarters and core operating margin improves.
• Avoid an unconditional short without valuation, borrow, and options-pricing data. For an existing long, consider a defined-risk put spread only if premiums are reasonable and Q4 channel metrics remain weak; cap risk at the premium.
• Treat Prysm as a watch item, not a valuation catalyst: request cohort-level new-customer conversion, repeat purchase, and revenue attribution. A sustained rise in those measures would challenge the cautious view; scan volume or aggregate conversion by itself would not.
• Track Q4 revenue and adjusted EPS against guidance, the $5 million transition-cost cash outlay, and cash/debt. A miss or renewed deterioration in core gross margin would strengthen the underweight; stabilization without channel recovery would not.